1. Home
  2. 研究室紹介
  3. 生命医科学研究センター

生命医科学研究センター 空間免疫制御理研ECL研究ユニット

理研ECL研究ユニットリーダー 佐藤 尚子(Ph.D.)


佐藤 尚子



  • 医歯薬学


  • 情報学
  • 生物学
  • 免疫学


  • 自然リンパ球
  • 疾患制御
  • 空間的免疫応答解析


  • 1. Matsumoto K., Okuyama K., Sidwell T., Yamashita M., Endo T., Satoh-Takayama N., Ohno H., Morio T., Rothenberg EV., and Taniuchi I.:
    "A Bacl11b N797/K variant isolated from an immunodeficient patient inhibits early thymocyte development in mice."
    Frontiers in Immunology. 2024. Doi: 10.3389/fimmu.2024.1363704.
  • 2. Mori A., Ohno H. and Satoh-Takayama N.:
    "Disease pathogenesis and barrier functions regulated by group 3 innate lymphoid cells."
    Seminars in Immunology. 2024. Doi: 10.1007/s00281-024-01000-1
  • 3. Ito A., Akama Y., Satoh-Takayama N., Saito K., Kato T., Kawamoto E., Gaowa A., Park EJ., Takao M., Shimaoka M.:
    "Possible metastatic stage-dependent ILC2 activation induces differential function of MDSCs through IL-13/IL-13Ra1 signaling during the progression of breast cancer lung metastasis."
    Cancers. 14(13): 3267, 2022. doi:10.3390/cancers14133267.
  • 4. Shi Z., Takeuchi T., Nakanishi Y., Kato T., Beck K., Nagata R., Kageyama T., Ito A., Ohno H. and Satoh-Takayama N.:
    "A Japanese Herbal formula, Daikenchuto, alleviates experimental colitis by reshaping microbial profiling and enhancing group 3 innate lymphoid cells."
    Frontiers in Immunology. 13: 903459, 2022. doi:10.3389/fimmu.2022.903459.
  • 5. Akama Y., Park EJ., Satoh-Takayama N., Gaowa A., Ito A., Kawamoto E., Darkwas S., Appiah M.G., Myint PK., Ohno H., Imai H. and Shimaoka M.:
    "Sepsis induces deregulation of IL-13 production and PD-1 expression in lung group 2 innate lymphoid cells."
    Shock. 55: 357-370, 2021. doi: 10.1097/SHK.0000000000001647.
  • 6. Satoh-Takayama N., Kato T., Motomura Y., Kageyama T., Taguchi-Atarashi N., Daitoku-Kinoshita R., Kuroda E., Di Santo JP., Mimuro H., Moro K. and Ohno H.:
    "Bacteria-induced group 2 innate lymphoid cells in the stomach provide immune protection through induction of IgA."
    Immunity. 52: 635-649, 2020. doi:10.1016/j.immuni.2020.03.002.
  • 7. Satoh-Takayama N., Serafini N., Verrier T., Rekiki A., Renauld JC. Frankel G. and Di Santo JP.:
    "CXCR6 controls the functional topography of IL-22 producing intestinal innate lymphoid cells."
    Immunity. 41: 776-788, 2014. doi:10.1016/j.immuni.2014.10.007.
  • 8. Satoh-Takayama N., Lesjean-Pottier S., Sawa S,. Vosshenrich CA., Eberl G. and Di Santo JP.:
    "Lymphotoxin-beta receptor-independent development of intestinal IL-22-producing NKp46+ innate lymphoid cells."
    European Journal of Immunology. 41: 780-6, 2011. doi:10.1002/eji.201040851.
  • 9. Satoh-Takayama N., Lesjean-Pottier S., Vieira P., Sawa S., Eberl G., Vosshenrich CA. and Di Santo JP.:
    "IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subset from Id2-dependent precursors."
    Journal of Experimental Medicine. 207: 273-80, 2010. doi:10.1084/jem.20092029.
  • 10. Satoh-Takayama N., Vosshenrich CA., Lesjean-Pottier S., Sawa S., Lochner M., Rattis F., Mention JJ., Thiam K., Cerf-Bensussan N., Mandelboim O., Eberl G. and Di Santo JP.:
    "Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense."
    Immunity. 29: 958-70, 2008. doi:10.1016/j.immuni.2008.11.001.





佐藤 尚子


募集職種 応募締切
研究員または特別研究員募集(Y24020) ポストが決まり次第


〒230-0045 神奈川県横浜市鶴見区末広町1-7-22 北研究棟
Email: naoko.satoh [at] riken.jp